Egyptian International Pharmaceutical Industries Company reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EGP 899.33 million compared to EGP 785.65 million a year ago. Net income was EGP 185.89 million compared to EGP 167.19 million a year ago.